Stay updated on Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Sign up to get notified when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.

Latest updates to the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page
- Check5 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, representing a small metadata-level update to the page without changing the displayed study information.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Sweden location entry has been updated from Malmo to Malmö in Skåne County, Sweden, reflecting the correct city spelling in the study's location list.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now indicates a newer ClinicalTrials.gov site revision (“v3.5.3”) instead of the previous one (“v3.5.0”). This reflects a site/software version update rather than any change to the clinical study details.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check77 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check99 days agoChange DetectedRevision label updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atopic Dermatitis Comparison: Upadacitinib vs Dupilumab Clinical Trial page.